Neurology Alert – March 1, 2008
March 1, 2008
View Issues
-
Metabolomic Profiling: A Diagnostic Blood Test for Parkinson Disease?
Metabolomic profiling is a technique that measures and analyzes a large array of low molecular weight species in any chosen sample. Metabolomic analysis of plasma accurately distinguishes between subjects with Parkinson disease and healthy controls, thus providing a potential disease biomarker. -
Alcohol Intake and Stroke Risk: Can We Optimize Our Consumption?
Heavy alcohol consumption increases the risk of both ischemic and hemorrhagic stroke. -
Phrenic Nerve Conduction Study: Not New but Improved
Phrenic nerve conduction studies are technically difficult, but are useful in the evaluation of patients with diaphragmatic paralysis. -
Disruptive Behaviors in Alzheimer's Disease
Disruptive behaviors are a poor prognostic sign in patients with Alzheimer's disease. -
Prevention of Thromboembolism: Is There Hope?
Anticoagulation for the prevention of venous thromboembolization is underutilized worldwide. Risk of short-term interruption of warfarin therapy appears small. Treatment with idraparinux increases hemorrhage risk, as compared with vitamin K antagonists. -
Why Doesn't "Genetic" Epilepsy Seem to Run in Families?
Genetic susceptibility to epilepsy is a complex, polygenetic matrix that is heavily influenced by environmental factors. -
Pharmacology Watch
Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions. -
Clinical Briefs in Primary Care Supplement